Innovotech (TSXV:IOT) ROE % Adjusted to Book Value : -1.44% (As of Sep. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Innovotech ROE % Adjusted to Book Value?

Innovotech's ROE % for the quarter that ended in Sep. 2024 was -9.71%. Innovotech's PB Ratio for the quarter that ended in Sep. 2024 was 6.75. Innovotech's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -1.44%.

Innovotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Innovotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovotech ROE % Adjusted to Book Value Chart

Innovotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-1.34

2.49

6.36

-2.45

-5.08

Innovotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-12.02	-4.11	-8.84	-11.80	-1.44

Competitive Comparison of Innovotech's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Innovotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovotech's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Innovotech's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Innovotech ROE % Adjusted to Book Value Calculation

Innovotech's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-15.89%	/	3.13
	=	-5.08%

Innovotech's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-9.71%	/	6.75
	=	-1.44%

Innovotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Innovotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovotech Inc (TSXV:IOT) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2011 - 94 Street, Suite L131, Edmonton, AB, CAN, T6N 1H1

Website

https://www.innovotech.ca

Innovotech Inc is a Canada-based company that provides solutions to client biofilm problems through its biofilm contract research department. The core activities of the company are sales of its products, conducting contract research for outside customers, and research and development to identify products for future commercialization. The products of the company include human and fungal biofilm susceptibility tests, a seed treatment designed to combat bacterial and fungal diseases, and an assay used in growing microbial biofilms for research purposes. Geographically, the firm has a business presence in the United States, Canada, and the Rest of the world of which the majority of the revenue is derived from the United States.

Executives

James Gregory Timourian	Senior Officer
Bradley Alan Clark	Director
Alan Clyde Hayes Savage	10% Security Holder
Craig Milne	Director
David Shong-tak Tam	Director
Bernard Grobbelaar	Director